Texas Attorney General Paxton is suing the makers of acetaminophen, claiming the firms concealed potential risks that the drug created to children's neurological development.
This legal action follows four weeks after Former President Trump promoted an unverified association between using acetaminophen - referred to as paracetamol - while pregnant and autism in young ones.
The attorney general is filing suit against the pharmaceutical giant, which once produced the medication, the exclusive pain medication approved for women during pregnancy, and the current manufacturer, which now manufacturers it.
In a official comment, he claimed they "betrayed America by making money from suffering and marketing drugs regardless of the dangers."
The manufacturer says there is lacking scientific proof tying Tylenol to autism.
"These manufacturers deceived for years, knowingly endangering numerous people to boost earnings," Paxton, from the Republican party, stated.
The company commented that it was "deeply concerned by the perpetuation of misinformation on the safety of paracetamol and the likely effects that could have on the health of women and children in America."
On its website, Kenvue also mentioned it had "consistently assessed the applicable studies and there is lacking reliable evidence that shows a verified association between taking paracetamol and autism."
Groups representing doctors and health professionals share this view.
The leading OB-GYN organization has stated acetaminophen - the primary component in Tylenol - is one of the few options for expectant mothers to address discomfort and elevated temperature, which can create significant medical dangers if not addressed.
"In multiple decades of studies on the use of paracetamol in gestation, no reliable research has definitively established that the consumption of acetaminophen in any stage of pregnancy results in brain development issues in young ones," the group said.
The court filing cites current declarations from the previous government in asserting the medication is potentially dangerous.
In recent weeks, Trump generated worry from medical authorities when he advised pregnant women to "resist strongly" not to take Tylenol when unwell.
The FDA then released a statement that medical professionals should think about restricting the consumption of acetaminophen, while also stating that "a causal relationship" between the medication and autism in children has not been proven.
The Health Department head Robert F Kennedy Jr, who oversees the FDA, had pledged in spring to initiate "comprehensive study program" that would identify the origin of autism spectrum disorder in a matter of months.
But experts cautioned that discovering a sole reason of autism - thought by researchers to be the outcome of a complex mix of inherited and surrounding conditions - would prove challenging.
Autism spectrum disorder is a category of lifelong neurodivergence and impairment that influences how people encounter and engage with the surroundings, and is diagnosed using doctors' observations.
In his legal document, the attorney general - who supports Trump who is running for the Senate - asserts Kenvue and J&J "deliberately disregarded and tried to quiet the research" around acetaminophen and autism spectrum disorder.
This legal action seeks to make the firms "destroy any marketing or advertising" that asserts Tylenol is safe for pregnant women.
The court case parallels the grievances of a group of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in 2022.
A federal judge threw out the lawsuit, stating research from the family's specialists was lacking definitive proof.